BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32343849)

  • 1. Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation.
    Chen SY; Zhang HP; Li J; Shi JH; Tang HW; Zhang Y; Zhang JK; Wen PH; Wang ZH; Shi XY; He YT; Hu BW; Yang H; Guo WZ; Zhang SJ
    Hepatology; 2021 Feb; 73(2):738-758. PubMed ID: 32343849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia-Reperfusion Injury by Suppressing Transforming Growth Factor-β-Activated Kinase 1.
    Guo WZ; Fang HB; Cao SL; Chen SY; Li J; Shi JH; Tang HW; Zhang Y; Wen PH; Zhang JK; Wang ZH; Shi XY; Pang C; Yang H; Hu BW; Zhang SJ
    Hepatology; 2020 Mar; 71(3):1037-1054. PubMed ID: 31393024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulator of G-protein signaling 14 protects the liver from ischemia-reperfusion injury by suppressing TGF-β-activated kinase 1 activation.
    Zhang JK; Ding MJ; Liu H; Shi JH; Wang ZH; Wen PH; Zhang Y; Yan B; Guo DF; Zhang XD; Tao RL; Yan ZP; Zhang Y; Liu Z; Guo WZ; Zhang SJ
    Hepatology; 2022 Feb; 75(2):338-352. PubMed ID: 34455616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination.
    Chen Z; Hu F; Zhang Y; Zhang L; Wang T; Kong C; Hu H; Guo J; Chen Q; Yu B; Liu Y; Zou J; Zhou J; Qiu T
    Front Immunol; 2023; 14():1167667. PubMed ID: 37304282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.
    Zhou J; Qiu T; Wang T; Chen Z; Ma X; Zhang L; Zou J
    Clin Sci (Lond); 2019 Jan; 133(2):335-349. PubMed ID: 30622220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1-Dependent Manner in Mice.
    Yang L; Wang W; Wang X; Zhao J; Xiao L; Gui W; Fan H; Xia J; Li Z; Yan J; Alasbahi A; Zhu Q; Hou X
    Hepatology; 2019 Jan; 69(1):294-313. PubMed ID: 30076625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBC1Domain Family Member 25 deficiency aggravates cerebral ischemia-reperfusion injury via TAK1-JNK/p38 pathway.
    Zhang Z; Ma T; Fu Z; Feng Y; Wang Z; Tian S; Liu Z; Wei W; Li X; Chen J; Zhao W
    J Neurochem; 2022 Feb; 160(3):392-411. PubMed ID: 34837397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-Specific Peptidase 10 Protects Against Hepatic Ischaemic/Reperfusion Injury via TAK1 Signalling.
    Jiangqiao Z; Tianyu W; Zhongbao C; Long Z; Jilin Z; Xiaoxiong M; Tao Q
    Front Immunol; 2020; 11():506275. PubMed ID: 33133065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.
    Hu J; Zhu XH; Zhang XJ; Wang PX; Zhang R; Zhang P; Zhao GN; Gao L; Zhang XF; Tian S; Li H
    J Hepatol; 2016 Jan; 64(1):146-59. PubMed ID: 26334576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM27 protects against cardiac ischemia-reperfusion injury by suppression of apoptosis and inflammation via negatively regulating p53.
    Li Y; Meng Q; Wang L; Cui Y
    Biochem Biophys Res Commun; 2021 Jun; 557():127-134. PubMed ID: 33865220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways.
    Tao Q; Tianyu W; Jiangqiao Z; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z
    Int J Biol Sci; 2019; 15(8):1618-1629. PubMed ID: 31360105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP10 protects against cerebral ischemia injury by suppressing inflammation and apoptosis through the inhibition of TAK1 signaling.
    Wang L; Wu D; Xu Z
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1272-1278. PubMed ID: 31301769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke.
    Zeyen T; Noristani R; Habib S; Heinisch O; Slowik A; Huber M; Schulz JB; Reich A; Habib P
    J Mol Med (Berl); 2020 Jun; 98(6):833-847. PubMed ID: 32382778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression.
    Wang X; Mao W; Fang C; Tian S; Zhu X; Yang L; Huang Z; Li H
    J Hepatol; 2017 Sep; ():. PubMed ID: 28887166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal inhibition between the transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1.
    Kim SY; Shim JH; Chun E; Lee KY
    J Biol Chem; 2012 Jan; 287(5):3381-91. PubMed ID: 22167179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.
    Qin JJ; Mao W; Wang X; Sun P; Cheng D; Tian S; Zhu XY; Yang L; Huang Z; Li H
    J Hepatol; 2018 Nov; 69(5):1110-1122. PubMed ID: 29958938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Regulator of G Protein Signaling 5 Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Transforming Growth Factor Beta-Activated Kinase 1-c-Jun-N-Terminal Kinase/p38 Signaling.
    Wang J; Ma J; Nie H; Zhang XJ; Zhang P; She ZG; Li H; Ji YX; Cai J
    Hepatology; 2021 Jan; 73(1):104-125. PubMed ID: 32191345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage Notch1 inhibits TAK1 function and RIPK3-mediated hepatocyte necroptosis through activation of β-catenin signaling in liver ischemia and reperfusion injury.
    Xu D; Qu X; Tian Y; Jie Z; Xi Z; Xue F; Ma X; Zhu J; Xia Q
    Cell Commun Signal; 2022 Sep; 20(1):144. PubMed ID: 36114543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miR-148a in Mitigating Hepatic Ischemia-Reperfusion Injury by Repressing the TLR4 Signaling Pathway via Targeting CaMKIIα in Vivo and in Vitro.
    Zheng D; Li Z; Wei X; Liu R; Shen A; He D; Tang C; Wu Z
    Cell Physiol Biochem; 2018; 49(5):2060-2072. PubMed ID: 30244246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
    Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
    Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.